Newborn Jaundice Treatment Global Market Report 2026

Newborn jaundice treatment refers to medical interventions used to lower elevated bilirubin levels in infants that lead to yellowing of the skin and eyes. It includes therapeutic techniques that assist in breaking down or eliminating excess bilirubin from the infant's bloodstream to avoid complications. These treatments are intended to restore normal bilirubin levels safely while supporting healthy neonatal development.

The primary device types of newborn jaundice treatment include overhead phototherapy units, portable phototherapy units, and other device types. Overhead phototherapy units refer to fixed systems installed above the infant that provide controlled light exposure to reduce bilirubin levels in a clinical setting. The various modalities involved include conventional phototherapy, light emitting diode phototherapy, and fiber optic phototherapy, and the services include diagnostic and screening services, therapeutic and nursing services, and support and monitoring services. The various technologies involved include light emitting diode light sources, fluorescent, halogen, and fiberoptic systems, and they are utilized by several end users such as hospitals, neonatal intensive care units, pediatric clinics, and homecare settings.

Tariffs are influencing the newborn jaundice treatment market by raising the cost of imported phototherapy equipment, LED lighting systems, and specialized neonatal care devices used in hospitals and homecare environments. This is affecting affordability and procurement timelines, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments such as LED phototherapy systems and portable devices are most impacted because of their dependence on advanced optical and electronic components sourced globally. However, tariffs are also encouraging local production of neonatal care equipment, reinforcing regional supply chains, and driving innovation in affordable phototherapy solutions for newborn care.

The newborn jaundice treatment market research report is one of a series of new reports from The Business Research Company that provides newborn jaundice treatment market statistics, including newborn jaundice treatment industry global market size, regional shares, competitors with a newborn jaundice treatment market share, detailed newborn jaundice treatment market segments, market trends and opportunities, and any further data you may need to thrive in the newborn jaundice treatment industry. This newborn jaundice treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The newborn jaundice treatment market size has grown strongly in recent years. It will grow from $2.71 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to high prevalence of neonatal jaundice cases globally, limited availability of advanced phototherapy devices in low-resource settings, reliance on conventional fluorescent lamp-based treatment systems, delayed diagnosis of hyperbilirubinemia in newborns, lack of standardized neonatal screening protocols.

The newborn jaundice treatment market size is expected to see strong growth in the next few years. It will grow to $3.49 billion by 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising adoption of LED-based phototherapy systems, increasing focus on early neonatal screening programs, growing demand for home-based newborn care solutions, advancements in non-invasive bilirubin monitoring technologies, expansion of neonatal intensive care infrastructure globally. Major trends in the forecast period include LED-based intensive phototherapy systems for rapid bilirubin reduction in neonates, fiber-optic blanket phototherapy enabling continuous treatment with minimal infant disruption, smart bilirubin monitoring systems integrated with real-time phototherapy adjustment, portable homecare phototherapy devices supporting early hospital discharge, dual-surface phototherapy units enhancing treatment efficiency in neonatal intensive care.

The rising birth rates are expected to drive the growth of the newborn jaundice treatment market in the coming years. Birth rates refer to the number of live births within a specific population during a given period, reflecting overall population growth and reproductive patterns. The increase in birth rates is supported by improved access to maternal healthcare, population expansion, and favorable government policies in certain regions, resulting in a larger number of newborns requiring postnatal care. Newborn jaundice treatment contributes to this trend by supporting early diagnosis and effective management of bilirubin levels in the expanding neonatal population through phototherapy and related treatment methods, thereby lowering the risk of complications. For instance, in July 2025, according to the Office for National Statistics, a UK-based government department, there were 594,677 live births recorded in England and Wales in 2024, an increase of 3,605 births (0.6%) compared to 2023, marking the first increase since 2021. Therefore, rising birth rates are driving the growth of the newborn jaundice treatment market.

Leading companies operating in the newborn jaundice treatment market are focusing on advanced non-invasive screening solutions, such as smartphone-based bilirubin detection technologies, to support early diagnosis and improve accessibility to care. Smartphone-based bilirubin detection uses mobile imaging and algorithm-based analysis of skin coloration to estimate bilirubin levels without requiring blood sampling or specialized equipment. For instance, in July 2024, Konica Minolta, a Japan-based technology company, collaborated with Picterus AS, a Norway-based digital health company, to strengthen non-invasive jaundice screening solutions. The collaboration utilizes smartphone-based imaging to support early detection, improve accessibility in low-resource settings, and enable timely intervention while maintaining screening accuracy. In addition, the solution reduces dependence on hospital-based diagnostic equipment and facilitates point-of-care screening in community and homecare environments. It also supports scalable neonatal screening programs by providing cost-effective and user-friendly technology for healthcare professionals.

In February 2026, Natus Sensory, a US-based medical technology company, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory expanded its neonatal care portfolio by integrating wearable phototherapy technology, strengthening innovation in bilirubin management solutions, and broadening treatment accessibility across hospital and alternative care environments. TheraB Medical is an Israel-based medical device company specializing in wearable phototherapy solutions for neonatal jaundice management.

Major companies operating in the newborn jaundice treatment market are Koninklijke Philips N. V., GE HealthCare Technologies, Dragerwerk AG & Co. KGaA, Heal Force Bio-Meditech Holdings Limited, Atom Medical, Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Gerate GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc., Cobams Srl, Kay & Company, Nareena Lifesciences Private Limited, Alfamedic, Delta

North America was the largest region in the newborn jaundice treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the newborn jaundice treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the newborn jaundice treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The newborn jaundice treatment market consists of revenues earned by entities by providing services such as diagnostic testing services, phototherapy treatment services, neonatal monitoring services, bilirubin screening services, and neonatal nursing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The newborn jaundice treatment market also includes sales of phototherapy devices, bilirubin monitoring systems, fiber optic phototherapy blankets, and neonatal care equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Newborn Jaundice Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses newborn jaundice treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for newborn jaundice treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The newborn jaundice treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Device Type: Overhead Phototherapy Units; Portable Phototherapy Units; Other Device Types
• 2) By Modality: Conventional Phototherapy; Light Emitting Diode Phototherapy; Fiber Optic Phototherapy
• 3) By Service Type: Diagnostic And Screening Services; Therapeutic And Nursing Services; Support And Monitoring Services
• 4) By Technology: Light Emitting Diode Light Sources; Fluorescent; Halogen; Fiberoptic
• 5) By End User: Hospitals; Neonatal Intensive Care Units; Pediatric Clinics; Homecare Settings
• Subsegments:
• 1) By Overhead Phototherapy Units: Light Emitting Diode Overhead Phototherapy Units; Fluorescent Lamp Overhead Phototherapy Units; Halogen Lamp Overhead Phototherapy Units; Double Surface Overhead Phototherapy Units
• 2) By Portable Phototherapy Units: Wearable Phototherapy Blanket Units; Fiber Optic Phototherapy Pad Units; Portable Light Emitting Diode Phototherapy Units; Compact Handheld Phototherapy Units
• 3) By Other Device Types: Phototherapy Bassinet Systems; Phototherapy Incubator Integrated Systems; Combination Phototherapy And Warming Units; Multisurface Phototherapy Systems
• Companies Mentioned: Koninklijke Philips N.V.; GE HealthCare Technologies; Dragerwerk AG & Co. KGaA; Heal Force Bio-Meditech Holdings Limited; Atom Medical; Ningbo David Medical Device; Fanem Ltd.; MTTS Inc.; Phoenix Medical Systems; Olidef Medical; Dixion Vertrieb Medizinischer Gerate GmbH; Anandic Medical Systems AG; Weyer GmbH; AVI Healthcare Pvt. Ltd.; Nice Neotech; Natus Medical; Ibis Medical; Novos Medical Systems; GINEVRI Srl; Solarc Systems Inc.; Cobams Srl; Kay & Company; Nareena Lifesciences Private Limited; Alfamedic; Delta
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.